Almac Pharma Services Appoints New VP Business Development

June 4, 2024

Almac Pharma Services, a member of the privately owned Almac Group providing innovative pharmaceutical development, manufacture and commercial services to global pharmaceutical and biotech organizations, has announced the appointment of Simon Wright as its new Vice President of Business Development.  

In his new role, Simon, who holds a BSc in Chemistry, will oversee Almac Pharma Services’ global business development and marketing strategy, in addition to supporting the Senior Leadership team in managing strategic business relationships with existing clients and developing opportunities to drive growth and market expansion for the business.

With a career spanning 30 years, Simon brings a wealth of experience in global business development, strategic leadership, and client relationship management. Most recently, Simon held the position of Head, Global Commercial Operations for Argenta where he was responsible for the management of new and existing customer relationships. Prior to this, he spent over 2 decades with Catalent where he held various senior business development roles and executed effective strategies for building strong relationships with internal teams and customers.

Welcoming Simon to the role, John McQuaid, President and Managing Director, Almac Pharma Services said, “We are delighted to have Simon on board. His experience, coupled with his deep industry knowledge and proven track record of developing successful partnerships, is a vital addition to our senior leadership team.  We look forward to working with him as, together, we drive continued growth and success for Almac Pharma Services.”

The appointment comes just 2 months after Almac Pharma Services announced the completion of a custom-built, high-volume facility significantly increasing its commercial manufacturing and packaging capacity, forming part of the Group’s ongoing global expansion investment program totalling £400m.


Back to news